Clinical utilization of long-acting granulocyte colony-stimulating factor (pegfilgrastim) prophylaxis in breast cancer patients with adjuvant docetaxel-cyclophosphamide chemotherapy

PURPOSE: Treatment with 4 cycles of docetaxel and cyclophosphamide (TC) in the adjuvant setting is associated with better outcomes than treatment with doxorubicin and cyclophosphamide (AC). However, Western guidelines have indicated that TC confers a high risk (>20%) of febrile neutropenia (FN),...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Ann Surg Treat Res
Päätekijät: Jeon, Ye Won, Lim, Seung Taek, Gwak, Hongki, Park, Seon Young, Shin, Juhee, Han, Hye Sug, Suh, Young Jin
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The Korean Surgical Society 2021
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7870427/
https://ncbi.nlm.nih.gov/pubmed/33585350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4174/astr.2021.100.2.59
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia